Volcano Corp (VOLC) 17.99 $VOLC
United States Electromedical and Electrotherapeutic Apparatus Market Report 2016 - Analysis And Forecast to 2020
M2 - Mon Jan 25, 9:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6mvcjq/u_s) has announced the addition of the "U.S. Electromedical And Electrotherapeutic Apparatus Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Electromedical And Electrotherapeutic Apparatus market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Electromedical equipment (including diagnostic, therapeutic, and patient monitoring equipment), excluding ionizing radiation equipment - Electronic hearing aids, complete units - Electromedical and electrotherapeutic apparatus manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - St. Jude Medical - Zimmer Biomet Holdings - Varian Medical Systems - Medtronic - Hologic - Abbott Vascular - Zoll Medical Corporation - Cyberonics - Fujifilm Sonosite - Biomerieux - Masimo Corporation - Starkey Laboratories - Volcano Corporation - Philips Ultrasound - Thoratec Corporation - Nxstage Medical - Danaher Corporation - Abiomed - GE Medical Systems Information Technologies - Natus Medical Incorporated - Conmed Corporation - Pacesetter - Amplifon (usa) - Zimmer - Cynosure - Mindray Ds Usa - Orchid Orthopedic Solutions - Zoll Services - Datex-Ohmeda - Medtronic Minimed - Terumo Cardiovascular Systems Corporation - Nellcor Puritan Bennett Incorporated - Cardiac Pacemakers - Halyard Sales For more information visit http://www.researchandmarkets.com/research/6mvcjq/u_s
ZBH: 124.89 (+2.87), MASI: 52.33 (+0.34), MDT: 88.36 (+0.87), MDSY: 1.55 (unch), DHR: 80.86 (+0.16), CYBX: 69.95 (+0.86), BABY: 39.65 (+0.57), VAR: 84.99 (+1.17), VOLC: 17.99 (+0.01), STJ: 80.58 (+0.43), THOR: 63.50 (+0.05), HOLX: 35.93 (+0.43)
EVS Broadcast Equipment appoints Yvan Absil as CFO of the company
Thomson Reuters ONE - Fri Nov 20, 1:00AM CST
EVS Broadcast Equipment, the leading provider of live video production systems, today announces the appointment of Yvan Absil as Senior Vice President and CFO of the company.
VOLC: 17.99 (+0.01)
Axsun Technologies announces acquisition, capital investment by Anzu Partners
M2 - Tue Oct 20, 4:07AM CDT
Axsun Technologies said it has been successfully divested from Volcano Corporation, a subsidiary of Royal Philips, and acquired by Anzu Partners, an investment firm based in Washington DC.
VOLC: 17.99 (+0.01)
Axsun Technologies announces acquisition and growth capital investment by Anzu Partners
PR Newswire - Mon Oct 19, 11:49AM CDT
Axsun Technologies announced that it has been successfully divested from Volcano Corporation, a subsidiary of Royal Philips, and acquired by Anzu Partners, an investment firm based in Washington DC. As part of the transaction, Axsun received a significant infusion of growth capital and an affiliate of Anzu Partners purchased the 65,000 square foot building in Billerica, MA that houses Axsun's operations.
VOLC: 17.99 (+0.01)
The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters) to 2019
M2 - Fri Jul 24, 8:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8qwd2/the_world_market) has announced the addition of the "The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters)" report to their offering. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. Angiography catheters are used in cardiological diagnostics. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia All of these catheters are included in this report. For many of these segments, company market share and regional breakout for US, Europe and Rest of World is provided. In addition to numbers that can be useful for business planning, the report provides analysis of the industry, including analysis of several important trends. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize Kalorama Information's World Market for Catheters. This report contains global market size and forecast to 2019 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Dialysis Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters - Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters - Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters - Suction Catheters - Wound Drainage Catheters Trends discussed in this report include the following: - Infection and Control - Vascular - Urinary - Catheter Intervention Trends - Catheter Malfunction - Antimicrobial Lock Solutions - Stroke Treatment - MRI Catheters - Sinus Balloon Catheter - Interventional Radiology - Heart Patch - PFO - New And Alternative Materials - Antiseptic-Coated Catheters Company profiles are included, with profiles of the following companies: - Abbott Laboratories - Angio Dynamics - Atrium Medical - Bactiguard Ab - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Covidien - Edwards Lifesciences - Greatbatch Medical - Johnson &Johnson - Flexicath - Hansen Medical - Iapyx Medical - Integra Lifesciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St.Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc. - Volcano Corp. - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/v8...rld_market
ZMH: 113.56 (+0.29), BSX: 23.90 (+0.24), ABT: 41.89 (+0.53), MDT: 88.36 (+0.87), HNSN: 3.97 (unch), VOLC: 17.99 (+0.01), EW: 104.72 (+0.97), VASC: 43.51 (+1.03)
Inferior Vena Cava Filters (IVCF) - Pipeline Review, 2015
M2 - Thu Jul 02, 8:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jmqw9g/inferior_vena) has announced the addition of the "Inferior Vena Cava Filters (IVCF) - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products. Scope - Extensive coverage of the Inferior Vena Cava Filters (IVCF) products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Inferior Vena Cava Filters (IVCF) - Pipeline Products under Development by Companies 5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview 6 Inferior Vena Cava Filters (IVCF)- Recent Developments 7 Appendix Companies Mentioned - Adient Medical Inc. - Bio2 Medical, Inc. - Contego Medical, LLC - Lifetech Scientific (Shenzhen) Co., Ltd. - NOvate Medical Technologies - Veniti, Inc. - Volcano Corporation - VueKlar Cardiovascular Ltd. For more information visit http://www.researchandmarkets.com/research/jm...erior_vena
VOLC: 17.99 (+0.01)
Global Interventional Cardiology & Peripheral Vascular Devices Market 2015 - Forecasts to 2019
M2 - Wed Jun 10, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6kzjg4/interventional) has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019" report to their offering. The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4% The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes. Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market. Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Angioplasty Market Size, By Type of Procedure 8 Angioplasty Balloons Market, By Type 9 Angioplasty Stents Market, By Type 10 Catheters Market, By Type 11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type 12 Inferior Vena Cava (IVC) Filters Market, By Type 13 Plaque Modification Devices Market, By Type 14 Hemodynamic Flow Alteration Devices Market, By Type 15 Accessories Market, By Type 16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region 17 Competitive Landscape 18 Company Profiles - Abbott Laboratories - B. Braun Melsungen AG - Boston Scientific Corporation - C.R. Bard - Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) - Medtronic, Inc. - Spectranetics International BV - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/6k...rventional
BSX: 23.90 (+0.24), SPNC: 20.24 (+0.30), JNJ: 122.85 (+0.34), ABT: 41.89 (+0.53), BCR: 239.00 (+1.20), MDT: 88.36 (+0.87), VOLC: 17.99 (+0.01), STJ: 80.58 (+0.43)
Volcano Shares Up 51.1% Since SmarTrend's Buy Recommendation (VOLC)
Comtex SmarTrend(R) - Thu Apr 23, 4:58PM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
Volcano Has Returned 51.1% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Thu Apr 16, 11:15AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
InnFocus Expands Board of Directors and Responsibilities
PR Newswire - Thu Apr 16, 7:30AM CDT
InnFocus, Inc. reports Director Randy Lindholm has been named Chairman of the Board. Mr. Lindholm was previously Chairman of the Board and CEO of Vidamed, until it was acquired by Medtronic. He was also Chairman of the Board of Crux Biomedical, until it was acquired by Volcano Corporation/Royal Philips. He has excellent experience in corporate financings and exits, and he has also served on numerous other medical device company boards including Barrx Medical, Estech, Microvention, Rita Medical, and Novasys Medical. Mr. Lindholm currently serves as a Director for publicly held Omnicell.
MDT: 88.36 (+0.87), VOLC: 17.99 (+0.01), OMCL: 35.90 (+0.79)
100 M&A Focused Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7d4bk7/manda_focused) has announced the addition of the "M&A Focused Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This report newly launched report identifies 100 M&A Focused medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Alliances and partnerships have traditionally been used to help companies reduce their funding and resource burden and provide potential upside. These non-dilutive sources of funding can take many forms and warrant a second look in the light of today's difficult economy. A panel of seasoned medical device executives will analyze several recent partnering deals and contemplate their usefulness as alternative funding sources. Practical take-away include: how to integrate product co-development into your innovation strategy, understanding the key differences in structuring partnership deals with large and small companies and universities and/or research centers, understanding the pitfalls, risks and opportunities that these partnering models present, and understanding how to leverage these relationships to create win-win scenarios to the benefit all participants. M&A environment in 2015 is anticipated to continue its strong growth trends. Strategic and private equity acquisition appetites for strong healthcare companies continue to grow and this offers tremendous liquidity opportunities for business owners. As strategic acquirers become increasingly aggressive in their pursuit of new sources of growth, the robust capital markets welcome the next wave of growth companies. Despite significant challenges in reimbursement and other operating factors, many healthcare providers continue to grow profitably by scaling their businesses. While this growth comes at a significant cost to gross margins, we see efficient companies continuing to generate strong overall profits and hence, attractive acquisition opportunities. Report Highlights: - M&A Focused 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of M&A Focused medical devices/technology/supplies companies with foreign companies - International presence of M&A Focused medical devices/technology/supplies companies - Key R&D activities by M&A Focused medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of M&A Focused Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 M&A Focused Medical Devices/Technology/Supplies Companies 3: Key News of M&A Focused Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of M&A Focused Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by M&A Focused Medical Devices/Technology/Supplies Companies 6: International Presence of M&A Focused Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of M&A Focused Medical Devices/Technology/Supplies Companies Companies Mentioned Sample list of company names included in this industry report: - 3M Company (United States) - Abaxis Inc (United States) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alfresa Pharma Corp (Japan) - Andon Health Company Limited (China) - Angiodynamics, Inc. (United States) - Anteo Diagnostics Limited (Australia) - Atcor Medical Holdings Ltd (Australia) - Azure Healthcare Ltd. (Australia) - Bio Rad Laboratories Incorporated (United States) - Bruker Corporation (United States) - Capitol Health Ltd (Australia) - Carefusion Corporation (United States) - Carl Zeiss Co., Ltd. (Japan) - Cellectis SA (France) - Coherent Incorporated (United States) - Cooper Companies Inc. (United States) - Corgenix Medical Corporation (United States) - Dynasil Corporation Of America (United States) - Heartware International Inc (Australia) - Hill-Rom Holdings, Incorporation (United States) - Jeol Limited (Japan) - Paragon Care Limited (Australia) - Smith & Nephew PLC (United Kingdom) - Tecan Group AG (Switzerland) - Veracyte, Inc. (United States) - Vitrolife AB (Sweden) - Volcano Corporation (United States) For more information visit http://www.researchandmarkets.com/research/7d...da_focused
MMM: 177.12 (+2.25), COO: 181.83 (+3.33), SNN: 34.44 (+0.37), VCYT: 4.99 (-0.05), ABAX: 50.95 (+2.54), DYSL: 1.45 (+0.04), VOLC: 17.99 (+0.01), CLLS: 25.15 (-1.57), COHR: 93.01 (+2.60), HRC: 51.37 (+0.57)
Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors
BusinessWire - Thu Apr 09, 6:35PM CDT
Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Kieran T. Gallahue and W. Anthony Vernon to the company's board of directors. Mr. Gallahue will serve as lead director and a member of the audit committee and Mr. Vernon will serve as chair of the nominating and corporate governance committee. Additionally, current director Casper de Clerq from Norwest Venture Partners has informed the board of directors that he will not seek re-election at the annual stockholder meeting in June.
MDVN: 62.10 (-0.64), XENT: 13.58 (+0.45), CFN: 59.91 (-0.06), VOLC: 17.99 (+0.01), ED: 80.38 (+0.39)
Shares of VOLC Up 51.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 09, 10:16AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
Uptrend Call Working As Volcano Stock Rises 51.1% (VOLC)
Comtex SmarTrend(R) - Thu Apr 09, 9:54AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
REVA Appoints Scott Huennekens to Board of Directors
GlobeNewswire - Wed Mar 25, 6:37PM CDT
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company"
today announced that Scott Huennekens, a recognized business executive in the medical device industry, has been appointed to its Board of Directors as a non-executive director.
VOLC: 17.99 (+0.01)
John Dahldorf Joins Benvenue Medical as Chief Financial Officer
BusinessWire - Mon Mar 23, 8:00AM CDT
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that John Dahldorf has joined the company as chief financial officer. Most recently Dahldorf was chief financial officer at Volcano Corporation.
VOLC: 17.99 (+0.01)
Volcano Up 51.1% Since SmarTrend Uptrend Call (VOLC)
Comtex SmarTrend(R) - Tue Mar 10, 5:11PM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 3 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
United States Electromedical and Electrotherapeutic Apparatus Market Report 2016 - Analysis And Forecast to 2020
M2 - Mon Jan 25, 9:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6mvcjq/u_s) has announced the addition of the "U.S. Electromedical And Electrotherapeutic Apparatus Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Electromedical And Electrotherapeutic Apparatus market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Electromedical equipment (including diagnostic, therapeutic, and patient monitoring equipment), excluding ionizing radiation equipment - Electronic hearing aids, complete units - Electromedical and electrotherapeutic apparatus manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - St. Jude Medical - Zimmer Biomet Holdings - Varian Medical Systems - Medtronic - Hologic - Abbott Vascular - Zoll Medical Corporation - Cyberonics - Fujifilm Sonosite - Biomerieux - Masimo Corporation - Starkey Laboratories - Volcano Corporation - Philips Ultrasound - Thoratec Corporation - Nxstage Medical - Danaher Corporation - Abiomed - GE Medical Systems Information Technologies - Natus Medical Incorporated - Conmed Corporation - Pacesetter - Amplifon (usa) - Zimmer - Cynosure - Mindray Ds Usa - Orchid Orthopedic Solutions - Zoll Services - Datex-Ohmeda - Medtronic Minimed - Terumo Cardiovascular Systems Corporation - Nellcor Puritan Bennett Incorporated - Cardiac Pacemakers - Halyard Sales For more information visit http://www.researchandmarkets.com/research/6mvcjq/u_s
ZBH: 124.89 (+2.87), MASI: 52.33 (+0.34), MDT: 88.36 (+0.87), MDSY: 1.55 (unch), DHR: 80.86 (+0.16), CYBX: 69.95 (+0.86), BABY: 39.65 (+0.57), VAR: 84.99 (+1.17), VOLC: 17.99 (+0.01), STJ: 80.58 (+0.43), THOR: 63.50 (+0.05), HOLX: 35.93 (+0.43)
EVS Broadcast Equipment appoints Yvan Absil as CFO of the company
Thomson Reuters ONE - Fri Nov 20, 1:00AM CST
EVS Broadcast Equipment, the leading provider of live video production systems, today announces the appointment of Yvan Absil as Senior Vice President and CFO of the company.
VOLC: 17.99 (+0.01)
Axsun Technologies announces acquisition, capital investment by Anzu Partners
M2 - Tue Oct 20, 4:07AM CDT
Axsun Technologies said it has been successfully divested from Volcano Corporation, a subsidiary of Royal Philips, and acquired by Anzu Partners, an investment firm based in Washington DC.
VOLC: 17.99 (+0.01)
Axsun Technologies announces acquisition and growth capital investment by Anzu Partners
PR Newswire - Mon Oct 19, 11:49AM CDT
Axsun Technologies announced that it has been successfully divested from Volcano Corporation, a subsidiary of Royal Philips, and acquired by Anzu Partners, an investment firm based in Washington DC. As part of the transaction, Axsun received a significant infusion of growth capital and an affiliate of Anzu Partners purchased the 65,000 square foot building in Billerica, MA that houses Axsun's operations.
VOLC: 17.99 (+0.01)
The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters) to 2019
M2 - Fri Jul 24, 8:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8qwd2/the_world_market) has announced the addition of the "The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters)" report to their offering. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. Angiography catheters are used in cardiological diagnostics. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia All of these catheters are included in this report. For many of these segments, company market share and regional breakout for US, Europe and Rest of World is provided. In addition to numbers that can be useful for business planning, the report provides analysis of the industry, including analysis of several important trends. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize Kalorama Information's World Market for Catheters. This report contains global market size and forecast to 2019 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Dialysis Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters - Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters - Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters - Suction Catheters - Wound Drainage Catheters Trends discussed in this report include the following: - Infection and Control - Vascular - Urinary - Catheter Intervention Trends - Catheter Malfunction - Antimicrobial Lock Solutions - Stroke Treatment - MRI Catheters - Sinus Balloon Catheter - Interventional Radiology - Heart Patch - PFO - New And Alternative Materials - Antiseptic-Coated Catheters Company profiles are included, with profiles of the following companies: - Abbott Laboratories - Angio Dynamics - Atrium Medical - Bactiguard Ab - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Covidien - Edwards Lifesciences - Greatbatch Medical - Johnson &Johnson - Flexicath - Hansen Medical - Iapyx Medical - Integra Lifesciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St.Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc. - Volcano Corp. - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/v8...rld_market
ZMH: 113.56 (+0.29), BSX: 23.90 (+0.24), ABT: 41.89 (+0.53), MDT: 88.36 (+0.87), HNSN: 3.97 (unch), VOLC: 17.99 (+0.01), EW: 104.72 (+0.97), VASC: 43.51 (+1.03)
Inferior Vena Cava Filters (IVCF) - Pipeline Review, 2015
M2 - Thu Jul 02, 8:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jmqw9g/inferior_vena) has announced the addition of the "Inferior Vena Cava Filters (IVCF) - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products. Scope - Extensive coverage of the Inferior Vena Cava Filters (IVCF) products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Inferior Vena Cava Filters (IVCF) - Pipeline Products under Development by Companies 5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview 6 Inferior Vena Cava Filters (IVCF)- Recent Developments 7 Appendix Companies Mentioned - Adient Medical Inc. - Bio2 Medical, Inc. - Contego Medical, LLC - Lifetech Scientific (Shenzhen) Co., Ltd. - NOvate Medical Technologies - Veniti, Inc. - Volcano Corporation - VueKlar Cardiovascular Ltd. For more information visit http://www.researchandmarkets.com/research/jm...erior_vena
VOLC: 17.99 (+0.01)
Global Interventional Cardiology & Peripheral Vascular Devices Market 2015 - Forecasts to 2019
M2 - Wed Jun 10, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6kzjg4/interventional) has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019" report to their offering. The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4% The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes. Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market. Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Angioplasty Market Size, By Type of Procedure 8 Angioplasty Balloons Market, By Type 9 Angioplasty Stents Market, By Type 10 Catheters Market, By Type 11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type 12 Inferior Vena Cava (IVC) Filters Market, By Type 13 Plaque Modification Devices Market, By Type 14 Hemodynamic Flow Alteration Devices Market, By Type 15 Accessories Market, By Type 16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region 17 Competitive Landscape 18 Company Profiles - Abbott Laboratories - B. Braun Melsungen AG - Boston Scientific Corporation - C.R. Bard - Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) - Medtronic, Inc. - Spectranetics International BV - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/6k...rventional
BSX: 23.90 (+0.24), SPNC: 20.24 (+0.30), JNJ: 122.85 (+0.34), ABT: 41.89 (+0.53), BCR: 239.00 (+1.20), MDT: 88.36 (+0.87), VOLC: 17.99 (+0.01), STJ: 80.58 (+0.43)
Volcano Shares Up 51.1% Since SmarTrend's Buy Recommendation (VOLC)
Comtex SmarTrend(R) - Thu Apr 23, 4:58PM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
Volcano Has Returned 51.1% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Thu Apr 16, 11:15AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
InnFocus Expands Board of Directors and Responsibilities
PR Newswire - Thu Apr 16, 7:30AM CDT
InnFocus, Inc. reports Director Randy Lindholm has been named Chairman of the Board. Mr. Lindholm was previously Chairman of the Board and CEO of Vidamed, until it was acquired by Medtronic. He was also Chairman of the Board of Crux Biomedical, until it was acquired by Volcano Corporation/Royal Philips. He has excellent experience in corporate financings and exits, and he has also served on numerous other medical device company boards including Barrx Medical, Estech, Microvention, Rita Medical, and Novasys Medical. Mr. Lindholm currently serves as a Director for publicly held Omnicell.
MDT: 88.36 (+0.87), VOLC: 17.99 (+0.01), OMCL: 35.90 (+0.79)
100 M&A Focused Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7d4bk7/manda_focused) has announced the addition of the "M&A Focused Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This report newly launched report identifies 100 M&A Focused medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Alliances and partnerships have traditionally been used to help companies reduce their funding and resource burden and provide potential upside. These non-dilutive sources of funding can take many forms and warrant a second look in the light of today's difficult economy. A panel of seasoned medical device executives will analyze several recent partnering deals and contemplate their usefulness as alternative funding sources. Practical take-away include: how to integrate product co-development into your innovation strategy, understanding the key differences in structuring partnership deals with large and small companies and universities and/or research centers, understanding the pitfalls, risks and opportunities that these partnering models present, and understanding how to leverage these relationships to create win-win scenarios to the benefit all participants. M&A environment in 2015 is anticipated to continue its strong growth trends. Strategic and private equity acquisition appetites for strong healthcare companies continue to grow and this offers tremendous liquidity opportunities for business owners. As strategic acquirers become increasingly aggressive in their pursuit of new sources of growth, the robust capital markets welcome the next wave of growth companies. Despite significant challenges in reimbursement and other operating factors, many healthcare providers continue to grow profitably by scaling their businesses. While this growth comes at a significant cost to gross margins, we see efficient companies continuing to generate strong overall profits and hence, attractive acquisition opportunities. Report Highlights: - M&A Focused 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of M&A Focused medical devices/technology/supplies companies with foreign companies - International presence of M&A Focused medical devices/technology/supplies companies - Key R&D activities by M&A Focused medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of M&A Focused Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 M&A Focused Medical Devices/Technology/Supplies Companies 3: Key News of M&A Focused Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of M&A Focused Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by M&A Focused Medical Devices/Technology/Supplies Companies 6: International Presence of M&A Focused Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of M&A Focused Medical Devices/Technology/Supplies Companies Companies Mentioned Sample list of company names included in this industry report: - 3M Company (United States) - Abaxis Inc (United States) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alfresa Pharma Corp (Japan) - Andon Health Company Limited (China) - Angiodynamics, Inc. (United States) - Anteo Diagnostics Limited (Australia) - Atcor Medical Holdings Ltd (Australia) - Azure Healthcare Ltd. (Australia) - Bio Rad Laboratories Incorporated (United States) - Bruker Corporation (United States) - Capitol Health Ltd (Australia) - Carefusion Corporation (United States) - Carl Zeiss Co., Ltd. (Japan) - Cellectis SA (France) - Coherent Incorporated (United States) - Cooper Companies Inc. (United States) - Corgenix Medical Corporation (United States) - Dynasil Corporation Of America (United States) - Heartware International Inc (Australia) - Hill-Rom Holdings, Incorporation (United States) - Jeol Limited (Japan) - Paragon Care Limited (Australia) - Smith & Nephew PLC (United Kingdom) - Tecan Group AG (Switzerland) - Veracyte, Inc. (United States) - Vitrolife AB (Sweden) - Volcano Corporation (United States) For more information visit http://www.researchandmarkets.com/research/7d...da_focused
MMM: 177.12 (+2.25), COO: 181.83 (+3.33), SNN: 34.44 (+0.37), VCYT: 4.99 (-0.05), ABAX: 50.95 (+2.54), DYSL: 1.45 (+0.04), VOLC: 17.99 (+0.01), CLLS: 25.15 (-1.57), COHR: 93.01 (+2.60), HRC: 51.37 (+0.57)
Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors
BusinessWire - Thu Apr 09, 6:35PM CDT
Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Kieran T. Gallahue and W. Anthony Vernon to the company's board of directors. Mr. Gallahue will serve as lead director and a member of the audit committee and Mr. Vernon will serve as chair of the nominating and corporate governance committee. Additionally, current director Casper de Clerq from Norwest Venture Partners has informed the board of directors that he will not seek re-election at the annual stockholder meeting in June.
MDVN: 62.10 (-0.64), XENT: 13.58 (+0.45), CFN: 59.91 (-0.06), VOLC: 17.99 (+0.01), ED: 80.38 (+0.39)
Shares of VOLC Up 51.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 09, 10:16AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
Uptrend Call Working As Volcano Stock Rises 51.1% (VOLC)
Comtex SmarTrend(R) - Thu Apr 09, 9:54AM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 4 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
REVA Appoints Scott Huennekens to Board of Directors
GlobeNewswire - Wed Mar 25, 6:37PM CDT
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company"
today announced that Scott Huennekens, a recognized business executive in the medical device industry, has been appointed to its Board of Directors as a non-executive director. VOLC: 17.99 (+0.01)
John Dahldorf Joins Benvenue Medical as Chief Financial Officer
BusinessWire - Mon Mar 23, 8:00AM CDT
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that John Dahldorf has joined the company as chief financial officer. Most recently Dahldorf was chief financial officer at Volcano Corporation.
VOLC: 17.99 (+0.01)
Volcano Up 51.1% Since SmarTrend Uptrend Call (VOLC)
Comtex SmarTrend(R) - Tue Mar 10, 5:11PM CDT
SmarTrend identified an Uptrend for Volcano (NASDAQ:VOLC) on December 11th, 2014 at $11.91. In approximately 3 months, Volcano has returned 51.11% as of today's recent price of $17.99.
VOLC: 17.99 (+0.01)
